• Skip to main navigation
  • Skip to search
  • Skip to main content
JKU & KUK Research Portal Home JKU & KUK Research Portal Logo
  • Help & FAQ
    • English
    • Deutsch
  • Home
  • Research units
  • Profiles
  • Research output
  • Projects
  • Activities
  • Datasets
  • Prizes
  • Press/Media
No photo of Markus Eidherr

Markus Eidherr

Dr.med.univ.

  • Department of Ophthalmology and Optometry
  • Faculty of Medicine
  • Emailmarkus.eidherrjkuat
  • Overview
  • Network
  • Research output (2)

Research output

  • 2 Article

Research output per year

Research output per year

  • Additional Effects of Faricimab in Aflibercept Low-Responders: Retinal Morphology and Function in Eyes with Neovascular Age Related Macular Degeneration Following a Switch Between Two Anti-VEGF Agents

    Rothbächer, J., Khalil, H., Eidherr, M. & Bolz, M., 03 Sept 2025, In: Clinical Ophthalmology. 19, p. 3145-3152 8 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
  • Reduced ocular perfusion after intravitreal Aflibercept and faricimab: an exploratory study for Tie2 receptor distribution in ophthalmic capillaries

    Schuhmayer, A. C., Karl, N. A. M., Pomberger, L., Eidherr, M., Khalil, H., Kallab, M., Strohmaier, C., Bolz, M. & Reisinger, A., 13 Oct 2025, (E-pub ahead of print) In: Graefe's Archive for Clinical and Experimental Ophthalmology. 8 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
JKU & KUK Research Portal Logo

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2025 JKU & KUK Research Portal, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure

Impressum

About web accessibility

Report vulnerability

Contact us